Michael F. Cannon

Michael F. Cannon is the Cato Institute’s director of health policy studies and the author of Recovery: A Guide to Reforming the U.S. Health Sector. Follow him @mfcannon.

High Prices of Prescription Drugs? Price Controls are Not the Answer

The federal government does countless things that increase prices for pharmaceuticals. If Trump wants to reduce drug prices, there are several steps he can take and steps that he should push Congress to take. Price controls are never the answer. 

No spam. Unsubscribe anytime.

Pin It on Pinterest